Cite this: Top Ten List in Pulmonary Vascular Disease - Medscape - Feb 01, 2005. Pulmonary Arterial Hypertension Guidelines Genetics and Pathophysiology of Pulmonary Vasculopathies ...

those with pulmonary vascular disease, or environmental lung disease. The pulmonary rehabilitation team of doctors, dietitians, and respiratory therapists hold a variety of.

At 12 weeks, patients treated with ENV-101 showed statistically significant increases in lung volume compared with those ...

Long-term exposure to particulate matter in patients with pulmonary arterial hypertension increases risk for lung transplantation or death.

Panelists discuss how managing patients with comorbidities requires careful evaluation to distinguish true Group 1 PAH features from underlying cardiac or pulmonary disease, with a more measured ...

If, in the course of this illness, pulmonary vascular disease develops with an increase in resistance, the pulmonary-artery pressure becomes elevated. 27 As noted earlier, the total hepatic blood ...

Among patients with pulmonary arterial hypertension, once-daily treprostinil palmitil inhalation powder for 16 weeks reduced ...

Shares of Insmed jumped Tuesday after the biopharmaceutical firm reported positive results from a Phase 2 trial for its ...

Resverlogix Corp. (TSX: RVX) ("Resverlogix", or the "Corporation") today held its Annual Meeting of Shareholders (the ...

BMPER attenuated PI3K/AKT signaling and suppressed BMP4-driven smooth muscle activation in models of PAH. BMPER overexpression mitigated the vascular remodeling that characterizes pulmonary arterial ...

Merck’s phase 3 HYPERION study of Winrevair meets primary endpoint in recently diagnosed adults with pulmonary arterial hypertension: Rahway, New Jersey Tuesday, June 24, 2025, ...

Emphysema subtypes, identified via CT, may be linked to cardiopulmonary subphenotypes that can help to target cardiac care in early COPD.